Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2026.1810204 Correction Correction: Case Report: renal allograft infiltration by chronic lymphocytic leukemia successfully treated with zanubrutinib AbboudBrian 1 * Writing – original draft Writing – review & editing RodriguezNehemias Guevara 2 Writing – original draft Writing – review & editing BabarArslan 2 Writing – original draft Writing – review & editing CoreasNoemy 3 Writing – original draft Writing – review & editing RobbinsKatherine 4 Validation Writing – original draft Writing – review & editing KunworRanju 2 Conceptualization Investigation Supervision Validation Writing – original draft Writing – review & editing Department of Internal Medicine, SSM Health-Saint Louis University School of Medicine, Saint Louis, MO, United States Division of Hematology, Oncology and Bone Marrow Transplant, Department of Internal Medicine, SSM-Health Saint Louis University School of Medicine, St. Louis, MO, United States Department of Gynecologic Oncology, Salvadoran Social Security Institute (ISSS), University of El Salvador (UES), San Salvador, El Salvador Department of Pathology, SSM-Health Saint Louis University School of Medicine, Saint Louis, MO, United States Correspondence: Brian Abboud, brian.abboud@slucare.ssmhealth.com 02 03 2026 2026 16 1810204 12 02 2026 17 02 2026 15 02 2026 Copyright © 2026 Abboud, Rodriguez, Babar, Coreas, Robbins and Kunwor. 2026 Abboud, Rodriguez, Babar, Coreas, Robbins and Kunwor https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Case Report: renal allograft infiltration by chronic lymphocytic leukemia successfully treated with zanubrutinib By Abboud B, Rodriguez NG, Babar A, Coreas N, Robbins K and Kunwor R (2026) Front. Oncol. 16:1765255. doi: 10.3389/fonc.2026.1765255 bruton tyrosine kinase (BTK) inhibitor CLL (chronic lymphocytic leukemia) hematology immunosuppression malignant hematologic disease renal transplant zanubrutinib zanubrutinib acute kidney injury as initial manifestation of chronic lymphocytic leukemia/small lymphocytic lymphoma section-at-acceptance Hematologic Malignancies

Author “Noemy Coreas” was erroneously spelled as “Noemy Coery”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland